酢酸カスポフンギン
|
|
- CAS番號(hào).
- 179463-17-3
- 化學(xué)名:
- 酢酸カスポフンギン
- 別名:
- 酢酸カスポフンギン;カスポファンギン酢酸塩;カスポファンジン酢酸塩;カスポファンギン酢酸塩 (JAN)
- 英語(yǔ)名:
- Caspofungin acetate
- 英語(yǔ)別名:
- Cancidas;Caspofungin Diacetate;(3S,6S,9S,11R,15S,18S,20R,21S,24S,25S)-21-(2-Aminoethylamino)-3-[3-amino-1(R)-hydroxypropyl]-6-[1(S),2(S)-dihydroxy-2-(4-hydroxyphenyl)ethyl]-18-(10,12-dimethyltetradecanamido)-11,20,25-trihydroxy-15-[1(R)-hydroxyethyl]-1,4,7,13,16,22-hexaazatricyclo[22.3.0.0(9,13)]heptacosane-2,5,8,14,17,23-hexaone diacetate;Mk0991;Mk 0991;L 743872;L-743872;L 743873;L-743,872;L 743,872
- CBNumber:
- CB51120146
- 化學(xué)式:
- C54H92N10O17
- 分子量:
- 1153.38
- MOL File:
- 179463-17-3.mol
|
酢酸カスポフンギン 物理性質(zhì)
- 融點(diǎn) :
- >105°C (dec.)
- 貯蔵溫度 :
- -20°C
- 溶解性:
- H2O: ソリュブル15mg/mL (透明溶液)
- 外見 :
- 粉
- 色:
- 白からベージュ
- 水溶解度 :
- H2O: 15mg/mL (clear solution)
- InChIKey:
- OGUJBRYAAJYXQP-LLXMLGLCSA-N
安全性情報(bào)
- リスクと安全性に関する聲明
- 危険有害性情報(bào)のコード(GHS)
WGK Germany |
3 |
|
|
RTECS 番號(hào) |
TP8046500 |
|
|
絵表示(GHS) |
|
注意喚起語(yǔ) |
警告 |
危険有害性情報(bào) |
コード |
危険有害性情報(bào) |
危険有害性クラス |
區(qū)分 |
注意喚起語(yǔ) |
シンボル |
P コード |
H315 |
皮膚刺激 |
皮膚腐食性/刺激性 |
2 |
警告 |
 |
P264, P280, P302+P352, P321,P332+P313, P362 |
H317 |
アレルギー性皮膚反応を起こすおそれ |
感作性、皮膚 |
1 |
警告 |
 |
P261, P272, P280, P302+P352,P333+P313, P321, P363, P501 |
H319 |
強(qiáng)い眼刺激 |
眼に対する重篤な損傷性/眼刺激 性 |
2A |
警告 |
 |
P264, P280, P305+P351+P338,P337+P313P |
H335 |
呼吸器への刺激のおそれ |
特定標(biāo)的臓器毒性、単回暴露; 気道刺激性 |
3 |
警告 |
 |
|
|
注意書き |
P261 |
粉じん/煙/ガス/ミスト/蒸気/スプレーの吸入を避ける こと。 |
P280 |
保護(hù)手袋/保護(hù)衣/保護(hù)眼鏡/保護(hù)面を著用するこ と。 |
P305+P351+P338 |
眼に入った場(chǎng)合:水で數(shù)分間注意深く洗うこと。次にコ ンタクトレンズを著用していて容易に外せる場(chǎng)合は外す こと。その後も洗浄を続けること。 |
|
酢酸カスポフンギン 価格
もっと(8)
メーカー |
製品番號(hào) |
製品説明 |
CAS番號(hào) |
包裝 |
価格 |
更新時(shí)間 |
購(gòu)入 |
富士フイルム和光純薬株式會(huì)社(wako)
|
W01TRCC184900 |
酢酸カスポフンギン
Caspofungin Acetate |
179463-17-3 |
5mg |
¥33300 |
2024-03-01 |
購(gòu)入 |
富士フイルム和光純薬株式會(huì)社(wako)
|
W01TRCC184900 |
酢酸カスポフンギン
Caspofungin Acetate |
179463-17-3 |
1mg |
¥20400 |
2023-06-01 |
購(gòu)入 |
富士フイルム和光純薬株式會(huì)社(wako)
|
W01TRCC184900 |
酢酸カスポフンギン
Caspofungin Acetate |
179463-17-3 |
25mg |
¥116900 |
2023-06-01 |
購(gòu)入 |
Sigma-Aldrich Japan
|
SML0425 |
カスポファンギン 二酢酸塩 ≥97% (HPLC)
Caspofungin diacetate ≥97% (HPLC) |
179463-17-3 |
5mg |
¥28300 |
2024-03-01 |
購(gòu)入 |
Sigma-Aldrich Japan
|
SML0425 |
カスポファンギン 二酢酸塩 ≥97% (HPLC)
Caspofungin diacetate ≥97% (HPLC) |
179463-17-3 |
25mg |
¥101000 |
2024-03-01 |
購(gòu)入 |
酢酸カスポフンギン 化學(xué)特性,用途語(yǔ),生産方法
効能
抗真菌薬, 細(xì)胞壁合成阻害薬
商品名
カンサイダス (MSD)
説明
Caspofungin is the first in a new class of antifungal agents named echinocandin to be
launched in the US for the parenteral treatment of invasive aspergillosis in patients
refractory to, or intolerant of other antifungal therapies such as amphotericin-B
1 lipid
formulation of amphotericin-B and/or itraconazole. Caspofungin is a water soluble, stable,
aza-substituted semisynthetic derivative of pneumocandin B, a fermentation product of the
fungus Zalerion arboricola. Since fungi and humans are both eukaryotes, new antifungal
agents must focus on fungus-specific targets in order to minimize potential toxicity in the
human host. In this respect, the lipopeptide caspofungin, inhibits the synthesis of 1,3-beta-
D-glucans present only in the fungal cell wall, which leads to the specific lysis of the
pathogenic cells. The compound is fungicidal rather than fungistatic, an unusual feature
among antifungal agents. Caspofungin has activity in vitro and in vivo against a range of
Candida species (including azole and amphotericin B resistant Candida) and also against
Aspergillus, an important pathogen which is not susceptible to fluconazole. Caspofungin
was generally more active than amphotericin B, flucytosine, fluconazole and itraconazole
against Candida species. Cryptococcus is not susceptible to caspofungin. Caspofungin
has a half-life in human beings around 10 hours. Unlike the azoles, caspofungin does not
inhibit cytochrome P450. The drug has been given intravenously with loading dose of 70
rag, followed by 50 mg daily to be effective in invasive aspergillosis refractory to prior
antifungal therapy. Most of the side effects were mild and comprised fever,
thrombophlebitis, headache, nausea, rash and flushing.
化學(xué)的特性
White Solid
使用
Caspofungin Diacetate is an impurity of Caspofungin Acetate(C184900) which is an echinocandin that inhibits the synthesis of β (1,3)-D-glucan, an integral component of the fungal cell wall. An antifungal drug used in the treatment of invasive fungal infections.
定義
ChEBI: The diacetate salt of caspofungin. It is used for the treatment of invasive candidiasis, and of aspergillosis in patients who are refractory to, or intolerant of, other therapy.
酢酸カスポフンギン 上流と下流の製品情報(bào)
原材料
準(zhǔn)備製品
酢酸カスポフンギン 生産企業(yè)
Global( 369)Suppliers
179463-17-3(酢酸カスポフンギン)キーワード:
- 179463-17-3
- Caspofungin acetate
- Caspofungin acetate [USAN:BAN:JAN]
- L 743,872
- L 743872
- L-743,872
- L-743872
- Mk 0991
- Mk0991
- Pneumocandin B0, 1-((4R,5S)-5-((2-aminoethyl)amino)-N2-(10,12-dimethyl-1-oxotetradecyl)-4-hydroxy-L-ornithine)-5-((3R)-3-hydroxy-L-ornithine)-, diacetate (salt)
- 1-[(4R,5S)-5-[(2-AMinoethyl)aMino]-N2-[(10R,12S)-10,12-diMethyl-1-oxotetradecyl]-4-hydroxy-L-ornithine]-5-(threo-3-hydroxy-L-ornithine)pneuMocandin B0 Diacetate
- 1-[(4R,5S)-5-[(2-AMinoethyl)aMino]-N2-[(10R,12S)-10,12-diMethyl-1-oxotetradecyl]-4-hydroxy-L-ornithine]-5-[(3R)-3-hydroxy-L-ornithine]pneuMocandin B0 Diacetate
- L 743873
- Cancidas, L-743,872, MK-0991
- Cancidas (Caspofungin Acetate)
- Pneumocandin B0, 1-[(4R,5S)-5-[(2-aminoethyl)amino]-N2-[(10R,12S)-10,12-dimethyl-1-oxotetradecyl]-4-hydroxy-L-ornithine]-5-[(3R)-3-hydroxy-L-ornithine]-, acetate (1:2)
- (3S,6S,9S,11R,15S,18S,20R,21S,24S,25S)-21-(2-Aminoethylamino)-3-[3-amino-1(R)-hydroxypropyl]-6-[1(S),2(S)-dihydroxy-2-(4-hydroxyphenyl)ethyl]-18-(10,12-dimethyltetradecanamido)-11,20,25-trihydroxy-15-[1(R)-hydroxyethyl]-1
- Caspofungin acetate
Cancidas
- 1-[(4R,5S)-5-[(2-Aminoethyl)amino]-N2-(10,12-dimethyl-1-oxotetradecyl)-4-hydroxy-L-ornithine]-5-[(3R)-3-hydroxy-L-ornithine]-pneumocandin B0
- Caspofungin diacetate, >=98%
- Casp ungin Acetate
- Caspofungin Acetate (L 743872
- Caspofungin Acetate for lnjection
- Cancidas, ≥98%
- Casporfungin Acetate
- CF/KB(EUGMP,GMP)
- L 743872;L 743873;MK 0991;MK-0991
- Caspofungin acetate USP/EP/BP
- Caspofungin diacetate salt
- Caspofungin acetate B0
- pofungin Acetate
- 酢酸カスポフンギン
- カスポファンギン酢酸塩
- カスポファンジン酢酸塩
- カスポファンギン酢酸塩 (JAN)